The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar ...

The HIV treatment landscape has further evolved with the introduction of LAI therapies, offering alternatives to daily oral ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

The Government of Ukraine, in consultation with partners, is exploring the use of unspent budget lines and Global Fund reprogramming to cover immediate gaps.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Patent pool is a consortium of two or more patent-holders to promote a particular technology and share the market ...

Current safety data suggest that lamivudine, telbivudine, or tenofovir may be used during pregnancy. However, the timing in initiating antiviral therapy requires careful assessment of risks and ...

Hepatitis B affects almost 300 million people worldwide, according to GSK, and while NAs to treat it are available – such as Gilead’s polymerase inhibitor Viread (tenofovir) – there is still ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

HBV affects almost 300 million people worldwide, according to GSK, and while drugs to treat it are available – such as Gilead's polymerase inhibitor Viread (tenofovir) – there is still no ...

Hospitals and clinics should plan to spend 11% to 13% more for prescription drugs in 2025 compared to last year, according to new research. For the second consecutive year, Keytruda was the costliest ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...